A young woman sits on a sofa at home. She appears to be in pain.

Endometriosis is a painful, chronic condition affecting millions of women worldwide. It occurs when tissue similar to the lining of the uterus (endometrium) grows outside the uterus. This tissue can grow on the ovaries, fallopian tubes, and other areas in the pelvis, causing inflammation and significant discomfort. It is estimated that approximately 10% of women of reproductive age are affected, making it one of the most common gynaecological conditions.  

Common Endometriosis Symptoms 

The most common symptoms of endometriosis include:

Endometriosis can also have a significant impact on mental health, increasing the risk of depression, anxiety, and other pain disorders.

The Challenges of Diagnosing and Treating Endometriosis

Unfortunately, endometriosis is often difficult to diagnose. It can take an average of 4 to 11 years from the onset of symptoms to receive a proper diagnosis. In the UK, this has not improved in recent years, with numbers suggesting that delays in diagnosis are continuing due to lengthy waiting lists to see a gynaecologist and other factors. In response, the Royal College of Obstetricians and Gynaecologists has recently released a report to help improve the care that women receive. The National Institute for Health and Care Excellence has similarly updated its guidance, aiming to improve diagnosis.

Current Treatment Options

Treatments for endometriosis may seek to either affect hormone levels, remove the endometrial deposits via surgery, or address symptoms. These may include:

Why a New Approach is Needed

Many current treatments come with limitations:

This is why many women with endometriosis are searching for alternative options to help them take control of their symptoms. Research suggests a significant number are turning to self-management strategies, including the use of cannabis.

The Endocannabinoid System and Endometriosis: A Potential Link

Emerging research suggests a possible connection between the endocannabinoid system (ECS) and endometriosis. The ECS is a complex network in the body that helps regulate pain, inflammation, mood, and other vital functions.

Medical Cannabis: A Growing Interest Among Endometriosis Patients

While clinical trials specifically on cannabis for endometriosis are still limited, many women are reporting positive experiences using it to manage their symptoms. A recent cross-sectional online survey conducted in German-speaking countries (Germany, Austria, and Switzerland) aimed to understand how women with endometriosis are using cannabis. Over 900 women with a confirmed endometriosis diagnosis participated.

Key Findings

What do these findings mean?

This survey adds to the growing body of evidence on the use of cannabis by women in experiencing endometriosis-related pain and other symptoms. Whilst these findings are not supported by evidence that is rigorous enough to suggest that medical cannabis is an appropriate first-line option for women experiencing endometriosis, it does support the need for future research using randomised controlled trials. 

Important Considerations

The Future of Medical Cannabis for Endometriosis

The research into cannabis for endometriosis is still in its early stages, but the initial findings are encouraging. There is a clear need for more effective and well-tolerated treatments for this debilitating condition.

Endometriosis and Curaleaf Clinic

If you have endometriosis and are interested in exploring medical cannabis, it is essential to speak with a healthcare professional to understand if you are eligible. They can also help patients understand the potential benefits and risks, discuss appropriate dosages and methods of use, and monitor their progress. If you are interested in exploring your suitability for a consultation further, you can sign up here.